Philadelphia Jury Rules Against Leukemia Suit

Jurors determined ExxonMobil gasoline was not defectively designed in a recent cancer-related lawsuit.

Updated on Oct. 20, 2026 in Oil and Gas

Philadelphia Jury Rules Against Leukemia Suit

Live Poll

Do you trust that large corporations are held fairly accountable for the health impacts of their products?

A Philadelphia jury has ruled that ExxonMobil gasoline was not defectively designed, rejecting claims brought by Leon and Ruth Mazza regarding a leukemia diagnosis. While the jury found the company failed to provide adequate warnings about benzene, it cleared ExxonMobil of intentionally concealing those risks.

Why it matters

The verdict highlights the ongoing legal battles surrounding benzene exposure linked to gasoline products. This decision stands in contrast to other significant litigation where courts have ruled against oil companies in cases involving similar claims.

A separate jury previously awarded Paul and Diane Gill $725.5 million in May 2024, a verdict the Pennsylvania Superior Court recently upheld. Meanwhile, legal proceedings continue regarding a separate 378,000-gallon gasoline leak at a Pennsylvania facility.

The players

ExxonMobil

This multinational oil and gas corporation faces numerous lawsuits across the United States regarding product safety and environmental impact.

Pennsylvania Superior Court

This intermediate appellate court manages cases across the Commonwealth and recently ruled on the validity of a major gasoline verdict.

Leon Mazza

The plaintiff in the recent Philadelphia lawsuit was diagnosed with leukemia before initiating his legal action against the energy company.

The details

The trial centered on whether the product design caused Leon Mazza to develop leukemia in 2022. The jury rejected the design defect allegations after the suit was filed in July 2023, leaving the failure-to-warn claim as the primary finding.

Leon Mazza received a leukemia diagnosis in 2022.
The lawsuit against ExxonMobil was filed in July 2023.
A jury awarded the Gill family $725.5 million in May 2024.
The jury in the Mazza case returned its verdict on Oct. 13, 2026.
The Pennsylvania Superior Court upheld the Gill verdict on Oct. 15, 2026.

Market Landscape

This case follows the precedent set by the Gill v. Mobil Oil verdict in terms of testing the legal liability of oil companies for health outcomes. The split outcomes demonstrate the volatility of mass-tort litigation facing major energy entities in the state.

While this verdict impacts specific litigants, it signals continued volatility for consumers following gasoline product litigation. Residents should monitor future legal filings regarding gasoline safety and benzene warnings in the region.

The takeaway

Legal outcomes for health-related claims against energy companies remain highly inconsistent across different jurisdictions. Patients and families considering litigation should consult with legal counsel to understand how previous appellate rulings may impact their specific case.